1. Home
  2. TKNO vs BNTC Comparison

TKNO vs BNTC Comparison

Compare TKNO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$9.11

Market Cap

482.7M

Sector

Health Care

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$9.23

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKNO
BNTC
Founded
1996
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.7M
396.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TKNO
BNTC
Price
$9.11
$9.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$9.00
★ $24.33
AVG Volume (30 Days)
★ 254.4K
138.5K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.86
6.67
EPS
★ N/A
N/A
Revenue
★ $40,520,000.00
N/A
Revenue This Year
$13.53
N/A
Revenue Next Year
$14.01
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 7.35
N/A
52 Week Low
$1.91
$9.26
52 Week High
$9.48
$16.76

Technical Indicators

Market Signals
Indicator
TKNO
BNTC
Relative Strength Index (RSI) 71.09 29.86
Support Level $4.87 N/A
Resistance Level $9.48 $13.75
Average True Range (ATR) 0.52 0.83
MACD 0.06 -0.12
Stochastic Oscillator 86.75 21.17

Price Performance

Historical Comparison
TKNO
BNTC

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: